Tubitak 1001; “Development of Targeted, Dual-Drug Delivery System and Investigation of Anticancer Activity” (Principle Investigator), 2017-2020 (Funded).

Tubitak 1003 (315S240); “Using Drag Reducing Polymer Instead of Blood and Blood Supplies during Hemorrhagic Shock” (Principle Investigator), 2017-2020 (Funded).

TUBITAK-3001 (115Z845); “Development of Biocompatible Graphene Platform for Biomedical Applications and Investigation of Cytotoxicity” (Principal Investigator), 2015-2016 (Funded).